Silas Deane
SILAS DEANE, the Nashville entrepreneur, sold VendEngine and its financial and communications technology offerings to Tyler Technologies (NYSE:TYL) for $84MM in 2021. He has experience in technology, healthcare, government relations and communications — with a passion for finding solutions to complex problems and creating/executing sustainable business models from them....
Padmakumar Kaimal, Ph.D.
Dr. Padmakumar (Kumar) Kaimal serves as Vice President, Technology Alliance & Business Development of Suven Life Sciences, New Jersey since 2003. Prior to joining Suven he was Director of Research and Development at Synthon Chiragenics from 1999 to 2003. Kumar has extensive career experiences in drug discovery, development and CRO.…...
Dr. Karen Burke
Karen Burke is a Clinical Professor and research scientist in the Department of Dermatology at Mt. Sinai Medical Center (NY, NY) with a private practice in dermatology. After her Ph.D. in biophysics at Cornell University and post-doctoral research at Weill Cornell Medical College and The Rockefeller University, she completed her…...
Franklin Salisbury, Jr., M.Div., J.D.
Franklin Salisbury, Jr. has a background in economics, law and religion. Trained in resource economics at Yale, he has spent his career fostering innovative collaborations with experts in different fields so they might work together to address and solve acute social, healthcare and environmental issues. Bachelors of Economics, Yale University…...
Alfred Slanetz, Ph.D.
Chairman of the Board Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since its incorporation in 2012. Geneius, an immuno-oncology start-up, is researching ways to help cancer patients’ immune…...
William J. Scandone
Board Director Mr. William J. Scandone currently serves as a Director of the Board of the the National Foundation for Cancer Research (NFCR). Bill has had engagements in the public, private, and government sectors. His experience includes pharmaceuticals, financial services, unions, universities, and government. He began his career negotiating contracts with…...
Joseph F. Franlin
Chairman of the Board Mr. Joseph Franlin is currently Chairman of the Board of the National Foundation for Cancer Research (NFCR). He has been in this position for three years, having served on the NFCR Board of Advisors and Board of Directors. Mr. Franlin was drawn to NFCR because of…...
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
Contact Us
-
5515 Security Lane, Suite 1105 Rockville, MD 20852
-
-
